Molecular and Biological Compatibility with Host Alpha-Synuclein Influences Fibril Pathogenicity
2016 · Cell Reports · 188 citations
https://doi.org/10.1016/j.celrep.2016.08.053
M
Matthew Byrne
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
698
Citations
10
h-index
10
i10-index
Matthew Byrne is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Parkinson's Disease Mechanisms and Treatments & Alzheimer's disease research and treatments & Neuroscience and Neuropharmacology Research. The author has an h-index of 10, co-authored 24 publications.
ORCID: 0000-0003-2510-1337Papers by this author
worksNeuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration
2017 · Acta Neuropathologica Communications · 58 citations
https://doi.org/10.1186/s40478-017-0471-3
Mutant LRRK2 in lymphocytes regulates neurodegeneration via IL-6 in an inflammatory model of Parkinson’s disease
2022 · npj Parkinson s Disease · 36 citations
https://doi.org/10.1038/s41531-022-00289-9
Templating of monomeric alpha-synuclein results in inflammation and SNpc dopamine neuron death in a genetic mouse model of induced synucleinopathy
2025 · Scientific Reports · 3 citations
https://doi.org/10.1038/s41598-025-10705-8
Automated Grading as Faculty Judgment at Scale
2026 · Nursing Education Perspectives · 0 citations
https://doi.org/10.1097/01.nep.0000000000001511
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat